SCHEMBL29567014

SCHEMBL29567014

Cc1ccccc1-c1cc(Oc2ccc(CO)cc2)nc(NS(=O)(=O)c2cccc(N)c2)n1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ TSHR P16473 2/20 0.39
▸ SMN1; SMN2 Q16637 2/20 0.39
▸ POLB P06746 1/20 0.38
▸ CA12 O43570 1/20 0.38
▸ CA1 P00915 1/20 0.38
▸ CA2 P00918 1/20 0.38
▸ CA9 Q16790 1/20 0.38
▸ MAPT P10636 1/20 0.37
▸ ALDH1A1 P00352 2/20 0.37
▸ PIK3C2B O00750 1/20 0.37
▸ PIK3C2G O75747 1/20 0.37
▸ PTGES2 Q9H7Z7 1/20 0.37
▸ PGR P06401 2/20 0.36
▸ PLAU P00749 1/20 0.36
▸ F2 P00734 1/20 0.36
▸ PRSS1 P07477 1/20 0.36
▸ PRSS2 P07478 1/20 0.36
▸ PRSS3 P35030 1/20 0.36
▸ LMNA P02545 1/20 0.36
▸ PRMT1 Q99873 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24309292 1.00 TSHR (0.39) TSHRSMN1; SMN2POLBCA12CA1
SCHEMBL26807167 0.92 MAPT (0.45) TSHRSMN1; SMN2POLBCA12CA1
SCHEMBL24309603 0.91 POLB (0.45) TSHRSMN1; SMN2POLBCA12CA1
SCHEMBL26807160 0.88 CA12 (0.41) TSHRSMN1; SMN2POLBCA12CA1
SCHEMBL26807174 0.88 CA12 (0.39) TSHRSMN1; SMN2POLBCA12CA1
SCHEMBL26807176 0.88 PLA2G7 (0.46) SMN1; SMN2POLBCA12CA1CA2
SCHEMBL24309286 0.86 PGR (0.48) MAPTALDH1A1PGRLMNATDP1
SCHEMBL29566653 0.86 PGR (0.48) MAPTALDH1A1PGRLMNATDP1
SCHEMBL26807170 0.86 SMN1; SMN2 (0.37) TSHRSMN1; SMN2POLBCA12CA1
SCHEMBL26807163 0.85 SMN1; SMN2 (0.40) TSHRSMN1; SMN2POLBCA12CA1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4225748-A1 MODULATORS OF CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR Vertex Pharmaceuticals Incorporated (US) 2023-08-16 — — EP disclosed
WO-2022076627-A1 MODULATORS OF CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR VERTEX PHARMACEUTICALS INCORPORATED (US) 2022-04-14 — — WO disclosed
Send feedback